Agenus Inc (NASDAQ:AGEN)
| 1.45 Delayed Data As of May 26 |  +0.04 / +2.84%Today’s Change | 1.23 Today|||52-Week Range 3.31 | -38.43% Year-to-Date |
Latest AGEN News | Press Releases
No recent news for Agenus Inc.
Today’s Trading
| Previous close | 1.41 |
| Today’s open | 1.45 |
| Day’s range | 1.37 - 1.45 |
| Volume | 3,204,194 |
| Average volume (3 months) | 4,894,089 |
| Market cap | $505.9M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -641.84% |
| Earnings growth (this year) | -4.26% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -66.85% |
| P/E ratio | NM |
| Price/Sales | 6.90 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | +0.09 | +1.79% |
| ANABAnaptysBio Inc | +0.01 | +0.05% |
| AUTLAutolus Therapeutics... | -0.22 | -7.21% |
| VYGRVoyager Therapeutics... | +0.11 | +0.92% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $98.0M |
| Annual profit (last year) | -$220.1M |
| Net profit margin | -224.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
